Urinary N-acetyl-β-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis

被引:18
|
作者
Erdener, D [1 ]
Aksu, K
Biçer, I
Doganavsargil, E
Kutay, FZ
机构
[1] Ege Univ Sch Med, Dept Clin Biochem, TR-35100 Izmir, Turkey
[2] Ege Univ Sch Med, Dept Rheumatol, Izmir, Turkey
[3] Ege Univ Sch Med, Dept Biochem, Izmir, Turkey
关键词
N-acetyl-beta-D-glucosaminidase; proteinuria; lupus nephritis; rheumatoid arthritis;
D O I
10.1002/jcla.20073
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Increased activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) can be used as an early indicator of damage to the tubular epithelium. Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease. Nephritis is known as the most serious complication of SLE and the strongest predictor of poor outcome. In this study urinary NAG excretion was investigated in 24 SLE patients with normal renal function (serum creatinine <= 1.2 mg/dL) and the results were compared with those from 26 untreated patients with rheumatoid arthritis (RA) and 27 healthy controls. The SLE patients were divided into two groups according to their urinary total protein levels: group A consisted of 16 patients with <= 3.5 g/day proteinuria, and group B consisted of eight patients with nephrotic-range proteinuria (>3.5 g/day). Serum and urinary creatinine, total urinary protein levels, and urinary NAG excretion were measured in patients with SLE and RA. In addition, serum C3 and C4 levels were determined in the SLE patients. Renal biopsies were performed in all of the SLE patients. Glomerular lesions were classified according to WHO criteria for lupus nephritis (LN) I-V. The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) was used to assess disease activity. Urinary NAG excretion was significantly higher in the SLE groups than in the healthy controls (P<0.001). In urinary NAG excretion there was also significant difference between SLE groups and RA patients (P<0.001). However, there was no significant difference in NAG excretion between the RA and control groups (P=0.062). Urinary NAG excretion was significantly higher (P<0.05) in group B compared to group A. There were no differences in SLEDAI scores, ages, and serum creatinine levels between study groups (P=0.601, P=0.285, P=0.669, respectively). Elevated SLEDAI values and hypocomplementemia were detected more often in younger patients (P<0.010, r=-0.529 and P<0.010, r=-0.569, respectively). There was a strong positive correlation between proteinuria and urinary NAG activity (P<0.001, r=0.759). These results suggest that the determination of urinary NAG activity may be a useful supplement to the routine biochemical analysis performed on the urine in cases of SLE.
引用
收藏
页码:172 / 176
页数:5
相关论文
共 50 条
  • [41] The Association between Urinary N-Acetyl-β-D-Glucosaminidase and Cardiovascular Autonomic Neuropathy in Patients with Diabetes
    Choi, Min Sun
    Jun, Ji Eun
    Kim, Gyuri
    Jin, Sang-Man
    Hur, Kyu Yeon
    Lee, Moon-Kyu
    Kim, Jae Hyeon
    DIABETES, 2018, 67
  • [42] Values for urinary β2-microglobulin and N-acetyl-β-D-glucosaminidase in normal healthy infants
    Nishida, M
    Kawakatsu, H
    Komatsu, H
    Ishiwari, K
    Tamai, M
    Tsunamoto, K
    Kasubuchi, Y
    Sawada, T
    ACTA PAEDIATRICA JAPONICA, 1998, 40 (05): : 424 - 426
  • [43] Effects of low-level arsenic exposure on urinary N-acetyl-β-D-glucosaminidase activity
    Eom, S-Y
    Lee, Y-C
    Yim, D-H
    Lee, C-H
    Kim, Y-D
    Choi, B-S
    Park, C-H
    Yu, S-D
    Kim, D-S
    Park, J-D
    Kim, H.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2011, 30 (12) : 1885 - 1891
  • [44] Urinary N-acetyl-β-d-glucosominidase in rheumatoid arthritis
    Iqbal, MP
    Ali, AA
    Waqar, MA
    Mehboobali, N
    EXPERIMENTAL AND MOLECULAR MEDICINE, 1998, 30 (03): : 165 - 169
  • [45] N-acetyl-β-D-glucosaminidase and inflammatory response after cardiopulmonary bypass
    Iqbal, Mohammad Perwaiz
    Sharif, Hasanat M.
    Mehboobali, Naseema
    Yousuf, Farzana A.
    Khan, Abrar H.
    Sellke, Frank W.
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2008, 18 (02): : 74 - 77
  • [46] Effect of tunicamycin on N-acetyl-β-D-glucosaminidase produced by Trichoderma harzianum
    Ulhoa, CJ
    Sankievicz, D
    Limeira, PS
    Peberdy, JF
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2001, 1528 (01): : 39 - 42
  • [47] Crystallization of GcnA, an N-acetyl-β-D-glucosaminidase, from Streptococcus gordonii
    Langley, DB
    Harty, DWS
    Graham, SC
    Guss, JM
    Hunter, N
    Collyer, C
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 : 1910 - 1911
  • [48] Analysis of urinary N-acetyl-β-D-glucosaminidase using 2,4-dinitrophenyl-1-thio N-acetyl-β-D-glucosaminide as the substrate
    Yamada, M
    Fujita, T
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2003, 17 (04) : 127 - 131
  • [49] URINARY N-ACETYL-β-D-GLUCOSAMINIDASE (NAG) LEVEL IS AN INDIRECT INDICATOR OF RENAL OUTCOMES BY SELECTIVELY REFLECTING RENAL TUBULAR LESION IN IGA NEPHROPATHY
    Song, Joon Ho
    Kim, Moon-Jae
    Lee, Seoung Woo
    Park, Geun Ho
    Lee, Seung Won
    NEPHROLOGY, 2005, 10 : A43 - A43
  • [50] Origin and significance of urinary N-acetyl-beta,D-glucosaminidase (NAG) in renal patients with proteinuria
    Costigan, MG
    Rustom, R
    Bone, JM
    Shenkin, A
    CLINICA CHIMICA ACTA, 1996, 255 (02) : 133 - 144